Introduction
According to the National cancer registry of Ukraine, in 2017, with ovarian, gastric and colorectal stage III cancer patients were diagnosed 43.4 %, 22.3 %, and 23.5 % of patients, respectively; stage IV -15.5 %, 37.8 % and 22.9 % of patients, respectively. Surgical and chemotherapeutic treatment are the main methods of control of these diseases and the radicality of the surgery largely determines the degree of response to the chemotherapy treatment and the overall and relapse-free survival of patients [1, 2] . At present, the main method of diagnosis of locally advanced processes in the abdomen is computed tomography with intravenous contrast (CT) [3] . Correct preoperative staging with the help of peritoneal index of carcinomatosis proposed by P. Shugarbaker allows to determine the order of combinated treatment, the expediency of surgical treatment and its probable volume and radicality [4, 5] . However, according to the literature, CT does not allow to achieve a significant correlation in the estimation of the extent of abdominal tumour and the possibility of its complete removal. Magnetic resonance imaging using diffuse-weighted imaging (DWI/MRI) can be a complement or alternative to CT in these cases [6, 7] .
The aim of the research -development and implementation of new methods of pre-operative staging of advanced ovarian, gastric and colorectal cancer to improve patient selection for cytoreductive surgery and increase its radicality.
Materials and methods
Clinical cases of 120 patients with advanced ovarian cancer (stage III and IV with final diagnosis), 28 with advanced gastric cancer (stage IV with final diagnosis) and 119 with advanced colorectal cancer (stage IV with final diagnosis) were considered. Preoperative detection of the incidence of peritoneal carcinoma and the possibility of surgery in radical or cytoreductive volume performed by CT with intravenous contrast (72 patients with ovarian cancer, 17 patients with gastric cancer, and 69 patients with colorectal cancer), and MR T1 and T2, contrast-enhanced T1, and diffuse-weighted sequences (48 patients with ovarian cancer, 11 patients with gastric cancer, and 50 patients with colorectal cancer). Subsequently, preoperative and intraoperative assessment of the incidence of tumour process by the peritoneal carcinomatosis index (PCI) by Sugarbaker was performed. Preoperative PCI restaging by both methods was performed by two radiologists independently including differences in statistical analysis to generate generalized values and compared with intraoperative evaluation. Patients were categorized by us according to the value of intraoperative PCI into three groups (PCI<10, 10<PCI<20, PCI>20), due to the complexity of achieving optimal cytoreduction in these cases of the prevalence of tumour process and the index of completeness of cytoreduction, which illustrated radicality intervention [8, 9] .
The research was carried out within the framework of the scientific work of the Department of Surgery No. 4 with the oncology course of the Odessa National Medical University. Compliance with the WMA Declaration of Helsinki -Ethical Principles for Medical Research Involving Human Subjects, 2013 (minutes of the meeting of the Committee on Bioethics of the Odessa National Medical University No. 167A dated September 12, 2019) was determined. All study participants were informed and agreed to the processing of their clinical data and to participate in the research process.
Statistical analysis of the obtained data was performed using GNU PSPP version 1.2.0 using the non-parametric Friedmann χ 2 test.
Results
In patients with ovarian cancer, DWI/MRI better revealed distant metastases in 8 out of 9 patients, compared to 2 in 15 with CT. In the category of patients with PCI<10, similar to intraoperative staging with DWI / MRI was obtained in 22 of 23 patients (95.7 %), versus 15 of 43 (34.9 %) with CT (p<0.05). In the category of patients with 10<PCI<20 DWI/MRI -13 out of 15 (86.7 %), CT 5 out of 17 (29.4 %) (p<0.05). In the category of patients with PCI>20 DWI / MRI -9 out of 10 (90 %), CT 3 out of 12 (25 %) (p <0.05) ( Fig. 1) . In patients with gastric cancer DWI/MRI, distant metastases were detected in 4 of 5 patients, compared with 6 of 11 in CT. In the category of patients with PCI<10, similar staging using DWI/MRI was obtained in 3 of 3 patients (100 %), versus 2 of 5 (40 %) at CT (p<0.05). In the category of patients with 10<PCI<20 DWI/MRI -3 out of 4 (75 %), CT 3 out of 7 (42.8 %) (p<0.05). In the category of patients with PCI>20 DWI / MRI -4 out of 4 (100 %), CT 3 out of 5 (60 %) (p <0.05) (Fig. 2) . In patients with colorectal cancer, DWI/MRI better revealed distant metastases in 7 out of 10 patients, compared with 3 in 10 with CT. In the category of patients with PCI<10, similar staging using DWI/MRI was obtained in 15 of 17 patients (88.2 %), versus 12 of 21 (57.1 %) with CT (p<0.05). In the category of patients with 10<PCI<20 DWI/MRI -18 out of 20 (90 %), CT 10 out of 32 (31.2 %) (p<0.05). In the category of patients with PCI>20 DWI/MRI -11 out of 13 (84.6 %), CT 5 out of 16 (31.2 %) (p<0.05) (Fig. 3) .
Fig. 3. The proportion of patients with similar preoperative and intraoperative staging with DWI/MRI and CT in colorectal cancer
Patients from all groups were categorized according to the completeness of cytoreduction index achieved through preoperative staging and patient selection using DWI/MRI and CT. Optimal CC-0 cytoreduction (no macroscopic residual tumor) and radical surgery were achieved in 53 % of patients staged with DWI/MRI and 46 % staged with CT (p<0.05). Suboptimal cytoreduction of CC-1 (residual tumor less than 2.5 mm) were achieved in 37 % of patients staged with DWI/MRI and 29 % staged with CT (p<0.05). Non-optimal CC-2-3 cytoreduction (residual lesions greater than 2.5 mm) were achieved in 10 % of patients staged with DWI/MRI and 25 % staged with CT (p<0.05) ( Fig. 4) . Fig. 4 . The proportion of patients among whom optimal (CC-0), suboptimal (CC-1) and nonoptimal (CC-2-3) cytoreduction was achieved with preoperative staging using DWI/MRI and CT
Discussion of the results
Compared with other studies of the efficacy and relative efficacy of DWI/MRI in colorectal cancer [10, 11] , ovarian cancer [12, 13] and stomach cancer [14, 15] , similar results are obtained, illustrating the reproducibility of the experiment regardless of the treatment center used, study protocols, and subjective evaluation of PCI ranking results.
Medicine and Dentistry
The obtained results allow us to recommend DWI/MRI for pre-operative staging at all three investigated localizations of the tumour process. Comparing the results of staging with DWI/MRI revealed a significant number of advantages over CT. First, DWI/MRI revealed a greater number of distant metastases, which in the future will allow in these cases to correctly select the stage of complex cancer treatment in patients requiring neoadjuvant chemotherapy before primary cytoreductive surgery [16] . Second, DWI/MRI in many cases of ovarian cancer revealed lesions of visually and palpatory unchanged regional lymph nodes. This fact will, in the long run, reduce the number of routine lymph node dissections in visually unaffected lymph nodes without reducing the radicalism of surgery and worsening the oncological results in these patients [17] . A similar situation arises when addressing the issue of extending standard volumes of lymph node dissection in gastric and colorectal cancer [18, 19] . Third, in the analysis of the local spread of the oncological process by the DWI/MRI method, the significant correlation of preoperative and intraoperative PCI allowed to predict better the future surgery, which made it possible to increase the radicality of the interventions. Also, CT sensitivity was limited by the size of tumors less than 5 mm and localization in certain anatomical areas (e. g. Omental foramen, lesser omentum, left hemidiaphragm and serous surface of the small intestine). However, a greater sensitivity of imaging with DWI/MRI was obtained in the presence of infiltrative and miliary carcinomatosis, which in many cases remained unnoticed in CT diagnosis, which dramatically changed the stage and volume of the operation. Better sensitivity of DWI/MRI, even at high PCI values, is also important, as it is in this group of patients that cases of inability to perform the optimal amount of cytoreductive intervention have been observed, which significantly impaired the predicted cancer outcomes. Despite these advantages, the relatively high cost, long study time, and the presence of absolute contraindications put the MRI on the second line for the detection and evaluation of tumors of the abdominal cavity.
Study limitations. This study was monocentric, nonrandomized and retrospective. The main limitation of the study is the retrospective recruitment of groups of patients who underwent surgery after pre-operative staging, and therefore did not include patients declared inoperable and patients with potentially suboptimal cytoreduction who were advised with neoadjuvant chemotherapy. The investigated data used the restaging of the pre-operative evaluation of the prevalence of the tumor process, conducted by two independent radiologists already at the time of the retrospective study, which in some cases differed from the conclusions obtained by patients during pre-operative diagnosis.
Prospects for further research. In the future, it is planned to compare the results obtained with the results of preoperative staging of widespread oncological processes by means of positron emission computed tomography and positron emission magnetic resonance imaging, which, like DWI/MRI, supplement information on molecular level disorders to the clear visualization of tissues and organs achieved by the main research [20] .
Conclusions
DWI/MRI significantly improves the pre-operative staging of advanced ovarian, gastric and colorectal cancer compared to CT, predicts the radicality of future surgery and identifies inoperable cases. DWI/MRI significantly outperforms CT in visualization of metastatic lesions of the peritoneum, abdominal organs, and extraperitoneal space for ovarian, gastric, and colorectal cancer. DWI/MRI can be used in planning of the treatment of these diseases, reducing the number of unnecessary exploratory laparotomies and suboptimal cytoreductive interventions.
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